Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales

Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales

ABSTRACT To assess the feasibility of oral fosfomycin-tromethamine (FT) for the management of acute bacterial prostatitis (ABP) caused by multidrug-resistant (MDR) Enterobacterales. An observational study of adult patients diagnosed with ABP from Vall d’Hebron University Hospital (Barcelona, Spain),...

Full description

Bibliographic Details
Main Authors: Joaquin Burgos, Yannick Hoyos-Mallecot, Carles Ferre-Losa, Maider Arando, Arnau Monforte, Tomas Pumarola, Ibai Los-Arcos, Vicenç Falcó
Format: Article
Language:English
Published: American Society for Microbiology 2023-10-01
Series:Microbiology Spectrum
Subjects:
fosfomycin-tromethamine
acute prostatitis
multidrug resistance
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02136-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.02136-23

Similar Items